Nishat S, Hossain M, Valentin G, Hossain F, Gamage S, Wall K
Vaccines (Basel). 2025; 12(12.
PMID: 39772036
PMC: 11680115.
DOI: 10.3390/vaccines12121375.
Puri K, Kulkarni S
Commun Chem. 2024; 7(1):204.
PMID: 39285253
PMC: 11405768.
DOI: 10.1038/s42004-024-01296-y.
Goodson H, Kawahara R, Fehring J, Purcell A, Croft N, Thaysen-Andersen M
Glycobiology. 2024; 34(11).
PMID: 39088576
PMC: 11441994.
DOI: 10.1093/glycob/cwae057.
Liu Y, Wu J, Hao H
Front Immunol. 2024; 15:1369110.
PMID: 38455058
PMC: 10917928.
DOI: 10.3389/fimmu.2024.1369110.
Zhang F, Guo X, Ye L, Yu S
Biochem Genet. 2024; 62(6):4619-4638.
PMID: 38347290
DOI: 10.1007/s10528-024-10678-9.
Intestinal Tr1 Cells Confer Protection against Colitis in the Absence of Foxp3+ Regulatory T Cell-Derived IL-10.
Zhou J, Glendenning L, Cavanaugh J, McNeer S, Goodman W, Cobb B
Immunohorizons. 2023; 7(6):456-466.
PMID: 37314833
PMC: 10580124.
DOI: 10.4049/immunohorizons.2200071.
Evaluation of Immune Modulation by β-1,3; 1,6 D-Glucan Derived from in Healthy Adult Volunteers, A Randomized Controlled Trial.
Chen S, Nan F, Liu M, Yang M, Chang Y, Chen S
Foods. 2023; 12(3).
PMID: 36766186
PMC: 9914031.
DOI: 10.3390/foods12030659.
Development in the Concept of Bacterial Polysaccharide Repeating Unit-Based Antibacterial Conjugate Vaccines.
Rohokale R, Guo Z
ACS Infect Dis. 2023; 9(2):178-212.
PMID: 36706246
PMC: 9930202.
DOI: 10.1021/acsinfecdis.2c00559.
Strengths and weaknesses of pneumococcal conjugate vaccines.
Micoli F, Romano M, Carboni F, Adamo R, Berti F
Glycoconj J. 2023; 40(2):135-148.
PMID: 36652051
PMC: 10027807.
DOI: 10.1007/s10719-023-10100-3.
Vaccine against Infection in Pig Based on Alternative Carrier Protein Conjugate.
Kralova N, Stepanova H, Gebauer J, Norek A, Matiaskova K, Zouharova M
Vaccines (Basel). 2022; 10(10).
PMID: 36298485
PMC: 9612095.
DOI: 10.3390/vaccines10101620.
Excretory/secretory proteins inhibit host immune responses by downregulating the TLR4/NF-κB/MAPKs signaling pathway: A possible mechanism of immune evasion in parasitic nematode .
Wen Z, Zhang Y, Feng J, Aimulajiang K, Aleem M, Lu M
Front Immunol. 2022; 13:1013159.
PMID: 36238295
PMC: 9551057.
DOI: 10.3389/fimmu.2022.1013159.
Polysaccharide from Koidz binding with zinc oxide nanoparticles: Characterization, immunological effect and mechanism.
Bo R, Liu X, Wang J, Wei S, Wu X, Tao Y
Front Nutr. 2022; 9:992502.
PMID: 36185684
PMC: 9520191.
DOI: 10.3389/fnut.2022.992502.
Glycoconjugates: Synthesis, Functional Studies, and Therapeutic Developments.
Shivatare S, Shivatare V, Wong C
Chem Rev. 2022; 122(20):15603-15671.
PMID: 36174107
PMC: 9674437.
DOI: 10.1021/acs.chemrev.1c01032.
Glycoconjugate Nanoparticle-Based Systems in Cancer Immunotherapy: Novel Designs and Recent Updates.
Barchi Jr J
Front Immunol. 2022; 13:852147.
PMID: 35432351
PMC: 9006936.
DOI: 10.3389/fimmu.2022.852147.
From Cancer Therapy to Winemaking: The Molecular Structure and Applications of β-Glucans and β-1, 3-Glucanases.
Caseiro C, Dias J, de Andrade Fontes C, Bule P
Int J Mol Sci. 2022; 23(6).
PMID: 35328577
PMC: 8949617.
DOI: 10.3390/ijms23063156.
Immunobiology of Carbohydrates: Implications for Novel Vaccine and Adjuvant Design Against Infectious Diseases.
Stefanetti G, Borriello F, Richichi B, Zanoni I, Lay L
Front Cell Infect Microbiol. 2022; 11:808005.
PMID: 35118012
PMC: 8803737.
DOI: 10.3389/fcimb.2021.808005.
Bacteria from Infectious Particles to Cell Based Anticancer Targeted Drug Delivery Systems.
Salem-Bekhit M, Youssof A, Alanazi F, Aleanizy F, Abdulaziz A, Taha E
Pharmaceutics. 2021; 13(12).
PMID: 34959266
PMC: 8706210.
DOI: 10.3390/pharmaceutics13121984.
Chimeric Antigen Receptors Expand the Repertoire of Antigenic Macromolecules for Cellular Immunity.
Keane J, Posey Jr A
Cells. 2021; 10(12).
PMID: 34943864
PMC: 8699116.
DOI: 10.3390/cells10123356.
Antigen presenting cell response to polysaccharide A is characterized by the generation of anti-inflammatory macrophages.
Zhou J, Zhou D, Telfer K, Reynero K, Jones M, Hambor J
Glycobiology. 2021; 32(2):136-147.
PMID: 34939104
PMC: 8934142.
DOI: 10.1093/glycob/cwab111.
β-Glucans Could Be Adjuvants for SARS-CoV-2 Virus Vaccines (COVID-19).
Cordova-Martinez A, Caballero-Garcia A, Roche E, Noriega D
Int J Environ Res Public Health. 2021; 18(23).
PMID: 34886361
PMC: 8656611.
DOI: 10.3390/ijerph182312636.